These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 23649748)

  • 21. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
    Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR
    Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentations of primary hypersomnia in Chinese children.
    Han F; Lin L; Li J; Aran A; Dong SX; An P; Zhao L; Li M; Li QY; Yan H; Wang JS; Gao HY; Li M; Gao ZC; Strohl KP; Mignot E
    Sleep; 2011 May; 34(5):627-32. PubMed ID: 21532956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep transitions in hypocretin-deficient narcolepsy.
    Sorensen GL; Knudsen S; Jennum P
    Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
    Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
    Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
    Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
    Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
    van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
    Sleep; 2022 May; 45(5):. PubMed ID: 35554594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
    Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
    Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias?
    Bozluolcay M; Nalbantoglu M; Benbir Senel G; Karadeniz D
    J Clin Neurophysiol; 2015 Aug; 32(4):364-8. PubMed ID: 26241245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
    Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
    Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
    Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
    Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
    Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
    Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
    Ruoff C; Rye D
    Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy.
    Hayduk R; Flodman P; Spence MA; Erman MK; Mitler MM
    Sleep; 1997 Oct; 20(10):850-7. PubMed ID: 9415944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocretin and human African trypanosomiasis.
    Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
    Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.